Sign In
Buy PLX
$1.96
-0.0300 (-1.51%)
At Close: Jun 03, 2026
Protalix Biotherapeutics, Inc. (PLX) Q2 2023 Earnings Call Transcript
10:10am, Monday, 07'th Aug 2023
Protalix BioTherapeutics, Inc. (NYSE:PLX ) Q2 2023 Earnings Conference Call August 7, 2023 8:30 AM ET Company Participants Charles Padala - IR Dror Bashan - President and CEO Eyal Rubin - SVP and CFO
Protalix BioTherapeutics Reports Second Quarter 2023 Financial and Business Results
06:50am, Monday, 07'th Aug 2023
Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel , Aug. 7, 2023 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focu
Protalix BioTherapeutics to Announce Second Quarter 2023 Financial and Business Results on August 7, 2023
06:50am, Monday, 31'st Jul 2023
Company to host conference call and webcast at 8:30 a.m. EDT CARMIEL, Israel , July 31, 2023 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused o
Protalix BioTherapeutics Stock: FDA Approval For Elfabrio To Drive Profitability
07:01am, Tuesday, 30'th May 2023
Protalix received FDA and EU approval for Elfabrio. This puts the company on track for profitability as early as 2023. With a reasonable valuation and strong growth, I see a significant potential upsi
Best Penny Stocks To Buy Today? 4 To Watch Under $5
10:46am, Thursday, 04'th May 2023
Penny stocks under $5 to watch this week. The post Best Penny Stocks To Buy Today?
Penny Stocks To Buy Now: 7 To Watch Before Next Week
11:05am, Friday, 17'th Mar 2023
Are these penny stocks to buy now or avoid entirely? The post Penny Stocks To Buy Now: 7 To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Best Penny Stocks To Buy Now: 3 To Watch Before Next Week
04:00pm, Wednesday, 15'th Mar 2023
Penny stocks to watch this week. The post Best Penny Stocks To Buy Now: 3 To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Penny Stocks To Buy Now? 7 Under $5 To Watch Before Next Week
12:20pm, Tuesday, 28'th Feb 2023
Cheap penny stocks to watch before next week. The post Penny Stocks To Buy Now?
Protalix Undervalued On CHMP Recommendation Of PRX-102 For Fabry Disease
06:52am, Sunday, 26'th Feb 2023
Protalix and Chiesi received a CHMP nod for PRX-102 (pegunigalsidase alfa). There is also an FDA PDUFA date of May 9, 2023.
The Prognosis For Protalix BioTherapeutics
03:42am, Friday, 10'th Feb 2023
Shares of plant-derived enzyme therapy concern Protalix BioTherapeutics, Inc. have rallied after its Fabry disease asset PLX-102 received a PDUFA date of May 9, 2023 from the FDA. The company is also
Best Penny Stocks To Buy? 4 To Watch Before 2023
02:07pm, Thursday, 29'th Dec 2022
Penny stocks to watch before next year. The post Best Penny Stocks To Buy?
Protalix BioTherapeutics, Inc. (PLX) Q3 2022 Earnings Call Transcript
11:50am, Monday, 14'th Nov 2022
Protalix BioTherapeutics, Inc. (NYSE:PLX ) Q3 2022 Results Conference Call November 14, 2022 8:30 AM ET Company Participants Chuck Padala - LifeSci Advisors Dror Bashan - President, CEO Eyal Rubin - S
Protalix BioTherapeutics to Report Third Quarter 2022 Financial and Business Results on November 14, 2022
06:50am, Monday, 07'th Nov 2022
Company to host conference call and webcast at 8:30 a.m. EST CARMIEL, Israel , Nov. 7, 2022 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company
Protalix BioTherapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
06:50am, Tuesday, 06'th Sep 2022
CARMIEL, Israel , Sept. 6, 2022 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercializati
Protalix BioTherapeutics Inc. (PLX) CEO Dror Bashan on Q2 2022 Results - Earnings Call Transcript
11:51am, Monday, 15'th Aug 2022
Protalix BioTherapeutics Inc. (NYSE:PLX ) Q2 2022 Earnings Conference Call August 15, 2022 8:30 AM ET Company Participants Chuck Padala - LifeSci Advisors, Investor Relations Dror Bashan - President,
